In Brief: Inamed
This article was originally published in The Gray Sheet
Executive Summary
Inamed: Chairman Donald McGhan assumes the additional title of CEO following the March 31 resignation of Michael Farney from the post. Farney will continue to serve as an outside consultant and focus on resolution of pending breast implant litigation. Jim McGhan, CEO of Inamed subsidiary McGhan Medical, is appointed to the additional post of president of Inamed...